URA has just announced a partnership with Dexcom that will allow the Oura Ring to help monitor your blood sugar.

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a ...

DexCom (NASDAQ:DXCM) is investing $75M in Finnish health tech firm ŌURA as part of the latter’s Series D funding round. ŌURA, ...

Oura has announced a new partnership that will bring an important new metric to its smart ring app. It has teamed up with ...

Diabetes care device developer Dexcom and ŌURA, maker of the Oura smart ring, have announced a strategic partnership that aim ...

Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors with the Oura Ring, which ...

A glucose screening test is a standard test during pregnancy to help identify gestational diabetes. The test is done in two steps and checks a pregnant person's response to glucose (sugar). High ...

Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company specializing in designing, developing, and commercializing continuous glucose ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

BUT IMAGINE GETTING $1,000 BILLS EVERY MONTH. YEAH, THAT’S THE SHOCKING REALITY FOR SOME PEOPLE WHO THINK THEIR ELECTRIC METERS MIGHT BE TO BLAME. THEY SAY TRYING TO GET A METER REPLACED HAS ...

In March, the FDA cleared Dexcom’s Stelo, making it the first glucose biosensor that doesn’t require a prescription. The small, wearable device, worn on the back of the upper arm, is designed ...